A2562
Angiotensinogen from human plasma
≥80% (SDS-PAGE)
Synonym(s):
Hypertensinogen, Renin substrate
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Biochem/physiol Actions
Angiotensinogen (renin substrate), a component of the rennin-angiotensin system, is a precursor protein to a family of blood pressure and hormone release regulating peptides known as the angiotensins.
Packaging
Package size based on protein content.
Physical form
Lyophilized powder containing sodium phosphate buffer, pH 7.
Analysis Note
Protein determined by A1%/280
Disclaimer
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
高风险级别生物产品--人源产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
脂肪组织中的胰岛素耐受性减少了循环游离脂肪酸的摄入，并增加了脂肪酶对储存甘油三酯的水解。了解与胰岛素耐受性相关的激素、细胞因子和脂肪因子。
Lipid Induced Insulin Resistance
D A Tewksbury
Federation proceedings, 42(10), 2724-2728 (1983-07-01)
Human angiotensinogen has been purified from outdated blood bank plasma. The purified angiotensinogen has a specific angiotensin I (Ang I) content of 20.7 micrograms Ang I/mg protein and contains only one amino-terminal amino acid, aspartic acid. However, it exhibits two
Weijian Shao et al.
American journal of physiology. Renal physiology, 304(5), F505-F514 (2013-01-11)
In angiotensin II (ANG II) infusion hypertension, there is an augmentation of intratubular angiotensinogen (AGT) and ANG II leading to increased urinary AGT and ANG II excretion rates associated with tissue injury. However, the changes in urinary AGT and ANG
The renal angiotensin system does not reveal its secrets with a cross-sectional analysis of urinary angiotensinogen levels.
Branko Braam
Journal of hypertension, 31(4), 840-840 (2013-03-08)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| A2562-.1MG | 04061832818887 |